A human growth hormone sequence is not just a string of amino acids on a product page. For research buyers, it is an identity benchmark. It distinguishes the expected mature protein from precursor material, alternate isoforms, truncations, substitutions, and poorly documented material that may look similar by name alone.
The reference most buyers mean is the predominant mature human growth hormone form: a single-chain protein containing 191 amino acids. That number is useful, but it is only the start of a credible identity review. Sequence context, molecular mass, structural features, and lot-specific analysis all matter when the goal is dependable research material.
What the Human Growth Hormone Sequence Refers To
Human growth hormone is initially produced as a longer precursor protein. The precursor includes a 26-amino-acid signal segment that directs processing inside the cell. Once that segment is removed, the mature reference form contains 191 amino acids.
This distinction prevents a common documentation error. A supplier may refer broadly to a 217-amino-acid precursor sequence, while a researcher is evaluating material expected to match the 191-amino-acid mature form. Those are related forms, but they are not interchangeable descriptions. Product documentation should make clear which form is being referenced.
The mature protein is commonly associated with an approximate mass of 22 kilodaltons. Molecular mass is a practical secondary checkpoint because it should generally align with the stated 191-residue composition. A mass result alone does not prove the full sequence, but a major mismatch should prompt questions before a buyer moves forward.
Why Sequence Identity Matters in Research Supply
Small changes can produce a materially different research item. A missing terminal residue, an altered amino acid, incomplete processing, or a mixed population can affect how a material behaves in an assay or analytical workflow. The label may still use a familiar compound name, which is why researchers should look beyond naming conventions.
Sequence identity also supports repeatability. If one lot is described only as “growth hormone” and another includes a defined sequence reference, molecular mass range, purity result, and lot documentation, the second option gives the buyer a clearer foundation for comparing results across purchases.
This is especially relevant in a market where shorthand product names are common. A name can identify a category. It cannot replace identity evidence. Quality-focused sourcing starts with asking whether the material matches the stated form and whether the supporting documentation is tied to the lot being purchased.
The 22 kDa and 20 kDa Forms Are Not the Same
The 191-amino-acid form is often called the 22 kDa form. Human growth hormone also has naturally occurring alternate forms, including a well-known 20 kDa isoform. The 20 kDa form results from alternative processing and lacks a segment of amino acids found in the 22 kDa reference form.
That difference is not academic. If a research project calls for the predominant 191-amino-acid sequence, a shorter isoform should not be treated as a direct match simply because both fall under the same broad name. The intended form should be stated in the specification, not inferred from a vial label or catalog category.
Structural Checks That Add Context
A sequence is linear on paper, but the resulting protein has higher-order structure. Human growth hormone contains cysteine residues that form disulfide bonds, helping stabilize its folded architecture. For the mature 191-amino-acid form, the established disulfide pairings are commonly described as Cys53-Cys165 and Cys182-Cys189.
These structural details matter because a correct amino acid count does not automatically establish a correctly characterized material. A sample can have the expected approximate mass while still requiring stronger evidence of identity, purity, and integrity. The appropriate level of scrutiny depends on the intended research use and the consequences of inconsistent input material.
Analytical methods are complementary rather than interchangeable. Mass spectrometry can support expected molecular mass and peptide mapping. Peptide mapping can provide stronger sequence-level confidence when compared with a defined reference. Chromatographic purity data can indicate the relative presence of major and minor species. Each answer addresses a different question.
A clean chromatogram, for example, may support purity within the method used. It does not independently establish that the main peak is the exact human growth hormone sequence claimed. Likewise, an expected intact mass can be encouraging but may not reveal every localized change. Reliable evaluation comes from reading the available results together.
What to Review Before Ordering Research Material
For a 191-amino-acid protein, documentation should be specific enough to connect the item in hand to the item described. A generic analysis sheet with no lot number, no method information, or no clear analyte name has limited value. The more expensive, sensitive, or repeat-dependent the work, the more important lot-level traceability becomes.
Start with the stated identity. The documentation should identify the mature 191-amino-acid form when that is the intended material and distinguish it from a precursor or alternate isoform. Next, compare the reported molecular mass with the expected range for that form. Slight differences may arise from method selection, ionization states, or reporting conventions, but unexplained gaps deserve clarification.
Then review purity in context. Purity percentages should identify the analytical method used and preferably show a trace or report rather than a standalone number. A reported percentage is useful only when buyers can see what it measures. The same applies to sequence confirmation: a clear reference to peptide mapping or a comparable identity method carries more weight than broad claims such as “high quality” or “verified.”
Finally, verify operational details. Lot number, storage guidance, format, quantity, packaging condition, and fulfillment handling all affect whether the material arrives ready for the research environment it was purchased for. Fast shipping is valuable, but it should sit alongside transparent analysis and careful inventory control rather than replace them.
Common Documentation Gaps
Several gaps should slow down a purchase decision. The first is an unclear amino acid count. If the product is presented as human growth hormone but does not specify whether it is the 191-amino-acid mature form, the buyer is left to assume too much.
The second is analysis that cannot be connected to the current lot. Old reports, cropped images, and results without a matching identifier offer less confidence than lot-specific documentation. The third is overreliance on purity language without identity evidence. A high reported purity value may describe the proportion of a primary peak, but it does not by itself validate the primary peak’s sequence.
A fourth concern is inconsistent naming across the listing, label, and report. Differences in formatting can be harmless, but differences in sequence length, stated mass, or form designation require resolution. Precision is a trust signal. Serious suppliers make it easier to verify what is being ordered.
Sequence Review Is a Purchasing Discipline
The best purchasing decision is not always the one with the lowest listed price. For sequence-defined research materials, the useful comparison is price relative to documentation, lot traceability, handling standards, and the ability to reorder comparable material. Large-quantity discounts can be valuable when the supplier’s records make ongoing consistency easier to assess.
For informed buyers, the human growth hormone sequence provides a practical filter: confirm the intended 191-amino-acid mature form, look for compatible mass and identity data, review purity with its method, and make sure results belong to the lot being offered. That process is direct, efficient, and far more reliable than purchasing on a compound name alone.
Biotech Labz Supply is built around that same standard: a curated research catalog, visible lab analysis, and straightforward ordering for buyers who expect clarity before checkout. When sequence-defined material is part of the workflow, precise documentation is not extra paperwork. It is part of the material itself.
